← Leaderboards
Dhaval Sanjeev Kolte
Massachusetts General Hospital
$770,122
Attributed
$770,122
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $196.1K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$770,122 · 1
By mechanism
K23$770,122 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Lidia Maria Veras Rocha De Moura$5,521,503
- David E Sosnovik$15,139,691
- Ana-Maria Vranceanu$21,139,129
- Christine S Ritchie$16,346,545
- Jocelyn Alexandria Carter$978,474
Others in their field
Other Rising Stars on “Evidence Base”
- Rashada Alexander · American Association For The Advancement Of Science$22,676,040
- John Alam · Eip Pharma, Inc.$10,411,018
- Songthip T. Ounpraseuth · Univ Of Arkansas For Med Scis$10,363,762
- Sabrina Paganoni · Massachusetts General Hospital$9,819,674
- Suma Babu · Massachusetts General Hospital$9,819,674
- Jinsy Andrews · Columbia University Health Sciences$9,819,674
Research focus
Evidence BaseFinancial HardshipDesignDevelopment PlansEvaluationAdoptedAdverse EventAmerican College Of SurgeonsAortic Valve ReplacementAortic Valve StenosisAwardAdvisory CommitteesBiometryCardiologyCardiovascular SystemCareerCareer DevelopmentCaringCharacteristicsComorbidityComparativeDeath RateDemographicsFunding
Grant awards (4)
Identifying Modifiable Practices Related to Outcome Variation and Enhancement in Transcatheter Aortic Valve Replacement (IMPROVE TAVR)$189,559
K23 · FY2025 · HL · contact PI
Identifying Modifiable Practices Related to Outcome Variation and Enhancement in Transcatheter Aortic Valve Replacement (IMPROVE TAVR)$196,061
K23 · FY2024 · HL · contact PI
Identifying Modifiable Practices Related to Outcome Variation and Enhancement in Transcatheter Aortic Valve Replacement (IMPROVE TAVR)$192,251
K23 · FY2023 · HL · contact PI
Identifying Modifiable Practices Related to Outcome Variation and Enhancement in Transcatheter Aortic Valve Replacement (IMPROVE TAVR)$192,251
K23 · FY2022 · HL · contact PI